Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy

Annals of Surgical Oncology

Volumn 18, Issue 2, 2011, Pages 421-430

  Tamandl, Dietmar ^a   Klinger, Markus ^a   Eipeldauer, Sandra ^a   Herberger, Beata ^a   Kaczirek, Klaus ^a   Gruenberger, Birgit ^a   Gruenberger, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER DILATATION; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER METASTASIS; LIVER NECROSIS; LIVER SINUSOID; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; SIDE EFFECT; SINUSOIDAL OBSTRUCTION SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951549930     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1317-4     Document Type: Article

References (32)

1. R Adam V Delvart G Pascal A Valeanu D Castaing D Azoulay, et al. 2004 Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg. 4 644 657 discussion 657-8
2. B Nordlinger H Sorbye B Glimelius GJ Poston PM Schlag P Rougier, et al. 2008 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet. 9617 1007 1016 (Pubitemid 351392040)
3. R Adam G Pascal D Castaing D Azoulay V Delvart B Paule, et al. 2004 Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg. 6 1052 1061 discussion 1061-4
4. B Gruenberger W Scheithauer R Punzengruber C Zielinski D Tamandl T Gruenberger 2008 Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases BMC Cancer. 8 120 18439246
5. DG Blazer III Y Kishi DM Maru S Kopetz YS Chun MJ Overman, et al. 2008 Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol. 33 5344 5351
6. L Rubbia-Brandt V Audard P Sartoretti AD Roth C Brezault M Le Charpentier, et al. 2004 Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer Ann Oncol. 3 460 466 (Pubitemid 38444550)
7. H Nakano E Oussoultzoglou E Rosso S Casnedi MP Chenard-Neu P Dufour, et al. 2008 Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy Ann Surg. 1 118 124
8. JN Vauthey TM Pawlik D Ribero TT Wu D Zorzi PM Hoff, et al. 2006 Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol. 13 2065 2072 (Pubitemid 46622116)
9. G Morris-Stiff YM Tan JN Vauthey 2008 Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases Eur J Surg Oncol. 6 609 614 (Pubitemid 351671976)
10. FG Fernandez J Ritter JW Goodwin DC Linehan WG Hawkins SM Strasberg 2005 Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases J Am Coll Surg. 6 845 853 (Pubitemid 40744790)
11. S Kandutsch M Klinger S Hacker F Wrba B Gruenberger T Gruenberger 2008 Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases Eur J Surg Oncol. 11 1231 1236
12. AZ Khan G Morris-Stiff M Makuuchi 2009 Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases J Hepatobiliary Pancreat Surg. 2 137 144
13. DE Kleiner EM Brunt M Van Natta C Behling MJ Contos OW Cummings, et al. 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology. 6 1313 1321 (Pubitemid 40770284)
14. V Trillet-Lenoir G Freyer P Kaemmerlen A Fond O Pellet C Lombard-Bohas, et al. 2002 Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria Br J Radiol. 899 903 908 (Pubitemid 35446457)
15. M Klinger S Eipeldauer S Hacker B Herberger D Tamandl M Dorfmeister, et al. 2009 Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases Eur J Surg Oncol. 5 515 520
16. L Rubbia-Brandt G Mentha B Terris 2006 Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases J Am Coll Surg. 1 199 200 (Pubitemid 41831492)
17. B Gruenberger D Tamandl J Schueller W Scheithauer C Zielinski F Herbst, et al. 2008 Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer J Clin Oncol. 11 1830 1835
18. Y Fong J Fortner RL Sun MF Brennan LH Blumgart 1999 Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg. 3 309 318 discussion 318-21
19. C Laurent A Sa Cunha P Couderc E Rullier J Saric 2003 Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases Br J Surg. 9 1131 1136 (Pubitemid 37152173)
20. D Ribero H Wang M Donadon D Zorzi MB Thomas C Eng, et al. 2007 Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases Cancer. 12 2761 2767 (Pubitemid 350250347)
21. MN VanSaun IK Lee MK Washington L Matrisian DL Gorden 2009 High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model Am J Pathol. 1 355 364
22. F Braet K Nagatsuma M Saito L Soon E Wisse T Matsuura 2007 The hepatic sinusoidal endothelial lining and colorectal liver metastases World J Gastroenterol. 6 821 825 (Pubitemid 46470289)
23. S Richard M Seigneur A Blann R Adams M Renard M Puntous, et al. 1996 Vascular endothelial lesion in patients undergoing bone marrow transplantation Bone Marrow Transplant. 5 955 959 (Pubitemid 26395212)
24. A Woywodt M Haubitz S Buchholz B Hertenstein 2004 Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation Bone Marrow Transplant. 12 1015 1023 (Pubitemid 40028832)
25. KA Paschos D Canovas NC Bird 2009 The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis Cell Signal. 5 665 674
26. KA Paschos D Canovas NC Bird 2010 The engagement of selectins and their ligands in colorectal cancer liver metastases J Cell Mol Med. 14 165 174 1:CAS:528:DC%2BC3cXlt1Oqsro%3D 19627399
27. M Narita E Hatano I Ikai A Miyagawa-Hayashino A Yanagida H Nagata, et al. 2009 A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction Ann Surg. 5 806 813
28. JC Becker H Fukui Y Imai A Sekikawa T Kimura H Yamagishi, et al. 2007 Colonic expression of heme oxygenase-1 is associated with a better long-term survival in patients with colorectal cancer Scand J Gastroenterol. 7 852 858 (Pubitemid 46897617)
29. O Soubrane A Brouquet S Zalinski B Terris C Brézault V Mallet, et al. 2010 Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome Ann Surg. 3 454 460
30. T Aloia M Sebagh M Plasse V Karam F Levi S Giacchetti, et al. 2006 Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases J Clin Oncol. 31 4983 4990 (Pubitemid 46631400)
31. K Washington KL Lane WC Meyers 1993 Nodular regenerative hyperplasia in partial hepatectomy specimens Am J Surg Pathol. 11 1151 1158 (Pubitemid 23313789)
32. Folprecht G, Gruenberger T, Bechstein WO, Raab H-R, Lordick F, Hartmann JT, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 2010;11:38-47.